Brokers have had it anywhere between $3.50-$7. However each...

  1. 6,881 Posts.
    lightbulb Created with Sketch. 1
    Brokers have had it anywhere between $3.50-$7. However each announcement has been met with a deafening Ho-hum often heading south...

    Awaiting the patent, ex-US approvals for Axiron, Recuvyra European launch and FDA decision, estradiol distributor for Europe, half year results on 22 February.

    Believe we are only expecting $7-8m for 2011-2012 but $40m 2012-2013. Retains its PDF status.

    Always talk of Lilly buying it out.

    Happy to be put right on those figures.

    GLTA KP

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.7¢
Change
0.000(0.00%)
Mkt cap ! $6.931M
Open High Low Value Volume
1.7¢ 1.7¢ 1.7¢ $9.181K 540.0K

Buyers (Bids)

No. Vol. Price($)
3 401277 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.7¢ 674874 3
View Market Depth
Last trade - 11.56am 25/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.